Telma AM 40 mg Tablet

Telma AM 40mg tablet is an antihypertensive combination medicine. The medicine is used to treat high blood pressure (hypertension) in adults. It contains two active ingredients is Telmisartan in (40mg) concentration and Amlodipine in (5mg) concentration.

They together work to lower the blood pressure effectively, decrease strain on the heart, and lower the risk of cardiovascular complications such as heart attack or stroke. Doctor's prescription is mandatory before using the tablet to avoid complications during the treatment.

​

• Treats high blood pressure (Hypertension)
  

Telma AM 40mg tablet cause several side effects that are easily manageable with certain treatment options. If any of the following symptoms persist or worsen consult the healthcare professional instantly:

• Fatigue (tiredness)
• Bradycardia
• Gastrointestinal disturbance
• Electrolyte imbalance
• The increased glucose level in the blood
• Postural hypotension
• Angioedema and urticaria
• Visual disturbance
• Breathlessness
• Muscle cramp
• Headache
• Dizziness
• Sleepiness
• Ankle swelling​

• Doctor prescription is required while using Telma AM 40mg tablet to ensure safe and effective treatment option.
• The tablet should be taken with or without food at the same time everyday to enhance the effectiveness, maintain consistent blood pressure and reduce the risk of side effects.
• Do not crush, chew or break the tablet as it decrease the effectiveness of the medication and alter its absorption.
  
  

• Telma AM 40mg tablet contains two drugs that lowers blood pressure by Angiotensin-II (constricts vessels), inhibiting calcium entry into muscles (relaxes vessels), and reducing excess fluid/sodium.
• Telmisartan(40mg) acts as an angiotensin II receptor blocker (ARB) which preventing vasoconstriction and narrowing of blood vessels. Amlodipine (5mg) is a calcium channel blocker that prevents calcium from entering vascular smooth muscle cells, causing blood vessels to relax and widen.
  

• McClellan, K. J., & Markham, A. (1998). Telmisartan. Drugs, 56(6). https://pubmed.ncbi.nlm.nih.gov/9878991/
• Sharpe, M., Jarvis, B., & Goa, K. L. (2001). Telmisartan: a review of its use in hypertension. Drugs, 61(10), 1501-1529. https://pubmed.ncbi.nlm.nih.gov/11558835/
• Wang, J. G., Palmer, B. F., Vogel Anderson, K., & Sever, P. (2023). Amlodipine in the current management of hypertension. The Journal of Clinical Hypertension, 25(9), 801-807. https://pubmed.ncbi.nlm.nih.gov/37551050/
• Şen, S., Demir, M., Yiğit, Z., & Üresin, A. Y. (2018). Efficacy and safety of s-amlodipine 2.5 and 5 mg/d in hypertensive patients who were treatment-naive or previously received antihypertensive monotherapy. Journal of Cardiovascular Pharmacology and Therapeutics, 23(4), 318-328. https://pubmed.ncbi.nlm.nih.gov/29649885/
• Messerli, F. H., Bakris, G. L., Ferrera, R. D., Houston, M. C., Petrella, R. J., Flack, J. M., ... & AVALON Investigators. (2006). Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial. The Journal of Clinical Hypertension, 8(8), 571-583. https://pubmed.ncbi.nlm.nih.gov/16896273/​​